Honoring the accomplishments and legacy of Rita Moreno.
- Last Action
- 12/11/2025
Actions
- 2025-02-06Sponsor introductory remarks on measure. (CR H535-536)
- 2025-02-04Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-04Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-04Introduced in House
- 2025-02-04Introduced in House
CRS Summary
As of 2025-02-04 (00)
Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act
This bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.
The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.
The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.
Cosponsors (18)
- Donald Davis (D-NC)
- Kevin Hern (R-OK)
- Scott Peters (D-CA)
- Mariannette Miller-Meeks (R-IA)
- William Keating (D-MA)
- Richard Hudson (R-NC)
- Shri Thanedar (D-MI)
- Gus Bilirakis (R-FL)
- Josh Gottheimer (D-NJ)
- Lloyd Smucker (R-PA)
- Janelle Bynum (D-OR)
- Thomas Kean (R-NJ)
- Dina Titus (D-NV)
- Andrea Salinas (D-OR)
- Neal Dunn (R-FL)
- Adam Gray (D-CA)
- Dan Crenshaw (R-TX)
- Robert Bresnahan (R-PA)
Subjects
- Health care costs and insurance
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.